Taken together, our results demonstrate that myeloma-derived BDNF can promote RANKL secretion by bone marrow stromal cells in the BM milieu through ERK pathway, and that antisense inhibition of endogenous BDNF in MM cells inhibits both osteoclastogenesis and tumor growth in vivo. This evidence concerns the gene TNFSF11 and plasma cell myeloma.